Imatinib in KIT-negative Systemic Mastocytosis
NCT01297777
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Systemic Mastocytosis
Interventions
DRUG:
Imatinib Mesylate
Sponsor
Hospital Virgen de la Salud